Skip to main content

Table 1 Baseline characteristics and comparisons between 86 women and 104 men with T1D

From: Midnight salivary cortisol secretion and the use of antidepressants were associated with abdominal obesity in women with type 1 diabetes: a cross sectional study

  All patients Women Men p a
N 190 86 104  
Age (years) 43 (32, 51; 18–59) 42 (31, 50) 45 (32, 53) 0.11
Diabetes duration (years) 20 (11, 29; 1–55) 18 (10, 29) 21 (12, 33) 0.20
Abdominal obesityb 29 (15) 21 (24) 8 (8) 0.002c
General obesityd 22 (12) 14 (16) 8 (8) 0.073c
HbA1c
 mmol/mol 63 (54, 71) 64 (54, 71) 62 (54, 68) 0.39
 % 7.9 (7.1, 8.6) 8.0 (7.1, 8.7) 7.8 (7.1, 8.4)  
Total cholesterol (mmol/l) 4.6 (4.1, 5.1) 4.6 (4.1, 5.4) 4.6 (4.1, 5.1) 0.39
LDL-cholesterol (mmol/l) 2.8 (2.4, 3.3) 2.7 (2.4, 3.3) 2.8 (2.4, 3.3) 0.97
Triglycerides (mmol/l) 0.9 (0.6, 1.2) 0.8 (0.6, 1.3) 0.9 (0.7, 1.2) 0.83
HDL-cholesterol (mmol/l) 1.6 (1.3, 1.8) 1.6 (1.4, 1.9) 1.5 (1.3, 1.7) 0.040
Systolic BP (mm Hg) 120 (115, 130) 120 (110, 130) 125 (120, 130) 0.006
Diastolic BP (mm Hg) 70 (70, 75) 70 (65, 75) 70 (70, 80) 0.009
Hypoglycaemia (severe episodes) 9 (5) 5 (6) 4 (4) 0.73c
Smokinge 16 (9) 5 (6) 11 (11) 0.30c
Physical inactivityf 19 (10) 9 (11) 10 (10) 0.81c
Physical activity (times/week)
 > 5 63 (38) 32 (39) 37 (36) 0.74g
 3–5 59 (32) 27 (33) 32 (32)
 1–2 36 (20) 14 (17) 22 (22)
 < 1 19 (10) 9 (11) 10 (10)
Depression 20 (10) 8 (9) 12 (12) 0.64c
Alexithymia 30 (16) 17 (20) 13 (12) 0.23c
Antidepressants 13 (7) 9 (10) 4 (4) 0.087c
Continuous subcutaneous insulin infusion 19 (10) 11 (13) 8 (8) 0.33c
Lipid lowering drugs 91 (48) 39 (45) 52 (50) 0.56c
Antihypertensive drugs 59 (31) 21 (24) 38 (36) 0.084c
Cardiovascular complications 7 (4) 2 (2) 5 (5) 0.46c
  1. Data are n (%) or median (q1, q3; min–max). aMann–Whitney U test unless otherwise indicated. bWC (meters): women ≥ 0.88/men ≥ 1.02. cFisher’s exact test. dBMI ≥ 30 kg/m2. Missing values (all/women/men): en = 5/3/2; fn = 7/4/3. gLinear-by-linear association